What’s new in β-lactamases?

被引：30

作者：

Patricia A. Bradford

机构：

[1] Wyeth-Ayerst Research,

来源：

Current Infectious Disease Reports | 2001年 / 3卷 / 1期

关键词：

Cephalosporin; Lactam; Antimicrob Agent; Clavulanic Acid; AmpC;

D O I：

10.1007/s11908-001-0054-z

中图分类号：

学科分类号：

摘要：

β-lactamases continue to be the leading cause of resistance to β-lactam antibiotics, among gram-negative bacteria. In recent years, both the incidence and the prevalence of extended-spectrum β-lactamases, inhibitor-resistant β-lactamases, AmpC-type enzymes, and both metallo-carbapenemases and nonmetallo-carbapenemases have increased. These β-lactamases provide resistance to oximino-cephalosporins, β-lactam/β-lactamase inhibitor combinations, cephamycins, and carbapenems, respectively. Strains expressing these β-lactamases will generate a host of therapeutic challenges as we begin the 21st century.

引用

页码：13 / 19

页数：6

共 196 条

[31]

Arlet G(1992)OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa Antimicrob Agents Chemother 36 1877-1882

[32]

Verdet C(1996)Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns J Clin Microbiol 34 1880-1884

[33]

Bauernfeind A(1996)Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: Comparison of the double-disk and three dimensional tests J Clin Microbiol 34 2997-3001

[34]

Schneider I(1998)Detection of extendedspectrum β-lactamase (ESBL)-producing strains by the Etest ESBL screen Clin Infect Dis 27 1064-1064

[35]

Jungwirth R(1998)Detection of extended-spectrum-β-lactamase-producing members of the family Enterobacteriaceae with the Vitek ESBL test J Antimicrob Chemother 42 535-538

[36]

Girlich D(1997)Detection and reporting of extended-spectrum β-lactamase (ESBL)-producing organisms in Connecticut Antimicrob Agents Chemother 41 647-653

[37]

Naas T(1999)Emergence of clinical isolates with decreased susceptibility to ceftazidime and synergistic effect with co-amoxiclav due to SHV-1 hyperproduction Antimicrob Agents Chemother 43 1657-1661

[38]

Bellais S(1996)Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia J Antimicrob Chemother 38 183-191

[39]

Nadjar D(1995)Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived β-lactamase in a clinical isolate of Klebsiella oxytoca Antimicrob Agents Chemother 33 2580-2582

[40]

Rouveau M(1999)Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 β-lactamase produced by Proteus mirabilis strains J Antimicrob Chemother 43 447-458

← 1 2 3 4 5 6 7 8 9 10 →